Unlike other pro-inflammatory cytokines, HMGB1 is a late appearing inflammatory cytokine and might become a unique target for treatment in sepsis, since it provides a sufficient time frame for clinical intervention against progressive inflammatory disorders [6]. The gene discussed is HMGB1; the disease is Sepsis.